Visual outcomes following high water-content hydrophobic acrylic trifocal intraocular lens implantation.

Autor: Suzuki T; Totsuka-ekimae Suzuki Eye Clinic, Yokohama, Japan., Ota Y; Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, 2-9-18 KandaMisaki-cho, Chiyoda-ku, Tokyo, 101-0061, Japan., Suzuki H; Zengyo Suzuki Eye Clinic, Fujisawa, Japan., Hata S; Yokohama Sky Eye Clinic, Yokohama, Japan., Minami K; Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, 2-9-18 KandaMisaki-cho, Chiyoda-ku, Tokyo, 101-0061, Japan. minami@miyata-med.ne.jp., Bissen-Miyajima H; Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, 2-9-18 KandaMisaki-cho, Chiyoda-ku, Tokyo, 101-0061, Japan.
Jazyk: angličtina
Zdroj: BMC ophthalmology [BMC Ophthalmol] 2024 Oct 28; Vol. 24 (1), pp. 469. Date of Electronic Publication: 2024 Oct 28.
DOI: 10.1186/s12886-024-03735-9
Abstrakt: Background: To prospectively evaluate binocular visual outcomes after implantation of trifocal intraocular lenses (IOLs) with high-water-content hydrophobic acrylic material in Japanese patients.
Methods: In 59 patients (mean age 65.1 ± 7.9 years), Clareon PanOptix (CNWTT0: Alcon) with a high-water-content hydrophobic acrylic material was implanted bilaterally. Three months postoperatively, binocular uncorrected visual acuity (BUCVA) and distance-corrected visual acuity (BDCVA) at distances of 5 m, 80, 60, and 40 cm, binocular defocus curves, and binocular photopic contrast sensitivity were examined. Subjective symptoms (night vision disturbance, glare, halos, haze, or blurry vision) were also assessed.
Results: The mean postoperative BUCVA/BDCVA at 5 m, 80 cm, 60 cm, and 40 cm were - 0.115/-0.163, -0.052/-0.047, -0.054/-0.075, and - 0.043/-0.067 logMAR, respectively. A smooth defocus curve, contrast sensitivity within the normal range, and acceptable subjective symptom rates were obtained.
Conclusions: The trifocal IOL, composed of a high-water-content hydrophobic acrylic material, provides good continuous binocular vision from distance to near.
Trial Registration: This investigator-initiated study was registered in the Japan Registry for Clinical Trials (identifier: jRCTs032220042) on April 26, 2022.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: